U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H18F2N6O3
Molecular Weight 416.3814
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JNJ-39393406

SMILES

CN(C)C(=O)CCN1N=C(NC2=CC3=C(OC(F)(F)O3)C=C2)N=C1C4=CC=NC=C4

InChI

InChIKey=IURMHZBQEYNQOH-UHFFFAOYSA-N
InChI=1S/C19H18F2N6O3/c1-26(2)16(28)7-10-27-17(12-5-8-22-9-6-12)24-18(25-27)23-13-3-4-14-15(11-13)30-19(20,21)29-14/h3-6,8-9,11H,7,10H2,1-2H3,(H,23,25)

HIDE SMILES / InChI

Molecular Formula C19H18F2N6O3
Molecular Weight 416.3814
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:31:43 UTC 2023
Edited
by admin
on Sat Dec 16 10:31:43 UTC 2023
Record UNII
T930SOU82P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JNJ-39393406
Common Name English
1H-1,2,4-TRIAZOLE-1-PROPANAMIDE, 3-((2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)AMINO)-N,N-DIMETHYL-5-(4-PYRIDINYL)-
Systematic Name English
Code System Code Type Description
CAS
953428-73-4
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
CAS
1421060-40-3
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
NO STRUCTURE GIVEN
FDA UNII
T930SOU82P
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
DRUG BANK
DB11867
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
ChEMBL
CHEMBL3545291
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
WIKIPEDIA
JNJ-39393406
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
EPA CompTox
DTXSID401110616
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
CLINICAL_TRIALS.GOV
NCT02677207
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY THE EFFECTS OF JNJ-39393406 ON PSYCHOMETRIC PERFORMANCE AND RESIDUAL DEPRESSIVE (JNJ-DEP)
PUBCHEM
16755766
Created by admin on Sat Dec 16 10:31:43 UTC 2023 , Edited by admin on Sat Dec 16 10:31:43 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
ALPHA 7 IN VITRO DATA: INCREASES MAX AGONIST RESPONSE 17 TO 20-FOLD.
Related Record Type Details
ACTIVE MOIETY